Concepts (701)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lymphedema | 39 | 2022 | 421 | 14.210 |
Why?
|
| Vascular Malformations | 29 | 2022 | 428 | 8.660 |
Why?
|
| Arteriovenous Malformations | 15 | 2022 | 386 | 6.520 |
Why?
|
| Hemangioma | 24 | 2021 | 738 | 5.560 |
Why?
|
| Lymphatic Vessels | 10 | 2022 | 325 | 4.070 |
Why?
|
| Bone Transplantation | 14 | 2016 | 932 | 3.060 |
Why?
|
| Lymphatic Abnormalities | 10 | 2018 | 134 | 2.810 |
Why?
|
| Reconstructive Surgical Procedures | 20 | 2021 | 2127 | 2.690 |
Why?
|
| Parietal Bone | 7 | 2016 | 46 | 2.590 |
Why?
|
| MAP Kinase Kinase 1 | 4 | 2020 | 352 | 2.550 |
Why?
|
| Lipectomy | 5 | 2021 | 106 | 2.320 |
Why?
|
| Lipomatosis | 5 | 2017 | 109 | 2.010 |
Why?
|
| Frontal Bone | 9 | 2016 | 108 | 1.990 |
Why?
|
| Skull | 10 | 2014 | 812 | 1.980 |
Why?
|
| Capillaries | 6 | 2021 | 781 | 1.930 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 5 | 2021 | 1671 | 1.910 |
Why?
|
| Lower Extremity | 13 | 2021 | 1069 | 1.900 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 7 | 2020 | 908 | 1.800 |
Why?
|
| Craniotomy | 11 | 2016 | 728 | 1.720 |
Why?
|
| Endothelial Cells | 15 | 2022 | 3433 | 1.670 |
Why?
|
| Sturge-Weber Syndrome | 5 | 2021 | 76 | 1.660 |
Why?
|
| Hemangioma, Capillary | 5 | 2018 | 60 | 1.620 |
Why?
|
| Skin Neoplasms | 13 | 2019 | 5335 | 1.470 |
Why?
|
| Facial Neoplasms | 3 | 2016 | 130 | 1.450 |
Why?
|
| Craniosynostoses | 8 | 2014 | 392 | 1.320 |
Why?
|
| Arteriovenous Fistula | 2 | 2021 | 294 | 1.320 |
Why?
|
| Skin Transplantation | 5 | 2020 | 1123 | 1.230 |
Why?
|
| Receptors, FSH | 2 | 2018 | 31 | 1.210 |
Why?
|
| Mutation | 23 | 2022 | 29491 | 1.160 |
Why?
|
| Obesity | 13 | 2022 | 12248 | 1.140 |
Why?
|
| Vascular Neoplasms | 3 | 2018 | 183 | 1.130 |
Why?
|
| Hemangioendothelioma | 3 | 2017 | 123 | 1.110 |
Why?
|
| Ear, External | 3 | 2020 | 164 | 1.100 |
Why?
|
| Neoplasms, Vascular Tissue | 2 | 2018 | 35 | 1.090 |
Why?
|
| Infant | 56 | 2021 | 34574 | 1.030 |
Why?
|
| Facial Bones | 3 | 2012 | 208 | 1.020 |
Why?
|
| Face | 7 | 2017 | 984 | 1.020 |
Why?
|
| Abnormalities, Multiple | 6 | 2020 | 1387 | 0.970 |
Why?
|
| Nevus, Pigmented | 2 | 2015 | 218 | 0.950 |
Why?
|
| Extremities | 5 | 2017 | 882 | 0.910 |
Why?
|
| Osteogenesis | 7 | 2021 | 1290 | 0.910 |
Why?
|
| Surgical Flaps | 6 | 2020 | 1635 | 0.910 |
Why?
|
| Child | 70 | 2022 | 74388 | 0.900 |
Why?
|
| Child, Preschool | 54 | 2021 | 41221 | 0.900 |
Why?
|
| Nose Neoplasms | 3 | 2015 | 249 | 0.890 |
Why?
|
| Upper Extremity | 5 | 2019 | 562 | 0.890 |
Why?
|
| Basketball | 1 | 2021 | 47 | 0.860 |
Why?
|
| Receptor, EphB4 | 1 | 2021 | 33 | 0.860 |
Why?
|
| Receptor, TIE-2 | 1 | 2021 | 188 | 0.830 |
Why?
|
| Humans | 181 | 2022 | 717280 | 0.820 |
Why?
|
| Hockey | 1 | 2021 | 90 | 0.820 |
Why?
|
| Adolescent | 60 | 2021 | 85143 | 0.810 |
Why?
|
| Soccer | 1 | 2021 | 120 | 0.780 |
Why?
|
| X-Ray Microtomography | 5 | 2012 | 421 | 0.770 |
Why?
|
| Ear Auricle | 2 | 2020 | 35 | 0.750 |
Why?
|
| Sclerotherapy | 7 | 2021 | 165 | 0.750 |
Why?
|
| GTP-Binding Protein alpha Subunits | 2 | 2017 | 96 | 0.740 |
Why?
|
| Veins | 3 | 2016 | 750 | 0.740 |
Why?
|
| Neovascularization, Pathologic | 5 | 2021 | 2716 | 0.720 |
Why?
|
| Wounds and Injuries | 4 | 2015 | 2416 | 0.710 |
Why?
|
| Male | 109 | 2021 | 351399 | 0.700 |
Why?
|
| Referral and Consultation | 3 | 2020 | 3472 | 0.700 |
Why?
|
| Cartilage Diseases | 1 | 2020 | 142 | 0.690 |
Why?
|
| Hypertrophy | 7 | 2017 | 577 | 0.690 |
Why?
|
| Dura Mater | 3 | 2016 | 294 | 0.680 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gq-G11 | 5 | 2021 | 134 | 0.680 |
Why?
|
| Head and Neck Neoplasms | 4 | 2014 | 2745 | 0.670 |
Why?
|
| Female | 100 | 2021 | 377934 | 0.660 |
Why?
|
| Propranolol | 2 | 2017 | 517 | 0.660 |
Why?
|
| Neuromuscular Diseases | 1 | 2020 | 262 | 0.650 |
Why?
|
| Sarcoma, Kaposi | 2 | 2017 | 361 | 0.650 |
Why?
|
| Young Adult | 38 | 2021 | 56249 | 0.650 |
Why?
|
| Liver Regeneration | 5 | 2008 | 222 | 0.640 |
Why?
|
| ras Proteins | 2 | 2020 | 1117 | 0.630 |
Why?
|
| Terminology as Topic | 5 | 2015 | 1620 | 0.620 |
Why?
|
| Parotid Neoplasms | 3 | 2017 | 162 | 0.620 |
Why?
|
| Beckwith-Wiedemann Syndrome | 1 | 2016 | 45 | 0.610 |
Why?
|
| Leg | 2 | 2019 | 1139 | 0.600 |
Why?
|
| Wound Healing | 7 | 2015 | 2800 | 0.600 |
Why?
|
| Hepatectomy | 5 | 2008 | 565 | 0.600 |
Why?
|
| Neoplastic Syndromes, Hereditary | 2 | 2015 | 224 | 0.600 |
Why?
|
| Intracranial Arteriovenous Malformations | 1 | 2019 | 386 | 0.590 |
Why?
|
| Dermabrasion | 1 | 2015 | 14 | 0.590 |
Why?
|
| Leg Injuries | 2 | 2021 | 187 | 0.590 |
Why?
|
| Hydroquinones | 1 | 2015 | 40 | 0.580 |
Why?
|
| Adrenal Cortex Hormones | 5 | 2015 | 1850 | 0.580 |
Why?
|
| Follicle Stimulating Hormone | 1 | 2018 | 730 | 0.580 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gi-Go | 1 | 2016 | 90 | 0.570 |
Why?
|
| Body Mass Index | 9 | 2021 | 12507 | 0.570 |
Why?
|
| Surgery, Plastic | 3 | 2008 | 561 | 0.570 |
Why?
|
| Lymphangiosarcoma | 1 | 2015 | 13 | 0.560 |
Why?
|
| MAP Kinase Kinase Kinase 3 | 1 | 2015 | 17 | 0.560 |
Why?
|
| Telangiectasis | 1 | 2015 | 76 | 0.560 |
Why?
|
| Suture Techniques | 3 | 2015 | 798 | 0.560 |
Why?
|
| Congenital Abnormalities | 1 | 2020 | 698 | 0.560 |
Why?
|
| Skin Diseases, Vascular | 1 | 2015 | 41 | 0.550 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2020 | 1320 | 0.540 |
Why?
|
| Myofibroma | 2 | 2018 | 52 | 0.540 |
Why?
|
| Facial Dermatoses | 1 | 2015 | 93 | 0.530 |
Why?
|
| Vasoconstrictor Agents | 2 | 2010 | 637 | 0.520 |
Why?
|
| Subcutaneous Tissue | 4 | 2021 | 147 | 0.520 |
Why?
|
| Epinephrine | 3 | 2010 | 811 | 0.520 |
Why?
|
| Triamcinolone | 1 | 2014 | 67 | 0.520 |
Why?
|
| Rabbits | 8 | 2016 | 5143 | 0.520 |
Why?
|
| Bone Regeneration | 3 | 2012 | 445 | 0.520 |
Why?
|
| Adrenergic beta-Antagonists | 3 | 2017 | 1230 | 0.520 |
Why?
|
| Lymph Node Excision | 1 | 2020 | 1200 | 0.510 |
Why?
|
| Adult | 49 | 2021 | 212470 | 0.510 |
Why?
|
| Tissue and Organ Harvesting | 5 | 2014 | 363 | 0.510 |
Why?
|
| Subcutaneous Fat | 1 | 2017 | 388 | 0.500 |
Why?
|
| Arm Injuries | 2 | 2012 | 155 | 0.500 |
Why?
|
| Cicatrix | 2 | 2016 | 694 | 0.490 |
Why?
|
| Blood Vessels | 2 | 2012 | 1162 | 0.490 |
Why?
|
| Granuloma, Pyogenic | 3 | 2020 | 50 | 0.490 |
Why?
|
| Inlays | 1 | 2012 | 8 | 0.480 |
Why?
|
| Vascular Diseases | 1 | 2021 | 1158 | 0.450 |
Why?
|
| Glucocorticoids | 4 | 2017 | 2108 | 0.450 |
Why?
|
| Ear, Middle | 1 | 2014 | 327 | 0.450 |
Why?
|
| Receptors, Somatotropin | 1 | 2012 | 78 | 0.440 |
Why?
|
| Genetic Predisposition to Disease | 5 | 2021 | 17432 | 0.440 |
Why?
|
| Down Syndrome | 2 | 2011 | 813 | 0.440 |
Why?
|
| Cheek | 1 | 2011 | 68 | 0.440 |
Why?
|
| Mastectomy | 1 | 2020 | 1703 | 0.440 |
Why?
|
| Dermatologic Agents | 1 | 2015 | 302 | 0.430 |
Why?
|
| Bone Resorption | 2 | 2012 | 742 | 0.420 |
Why?
|
| Pilomatrixoma | 1 | 2011 | 24 | 0.420 |
Why?
|
| Compartment Syndromes | 1 | 2012 | 145 | 0.410 |
Why?
|
| Transplantation, Autologous | 6 | 2014 | 2081 | 0.410 |
Why?
|
| Infant, Newborn | 23 | 2021 | 24744 | 0.410 |
Why?
|
| Phenotype | 6 | 2021 | 16404 | 0.410 |
Why?
|
| Hair Diseases | 1 | 2011 | 76 | 0.400 |
Why?
|
| Meningomyelocele | 1 | 2012 | 167 | 0.400 |
Why?
|
| Nevus, Epithelioid and Spindle Cell | 1 | 2011 | 66 | 0.400 |
Why?
|
| Prednisolone | 1 | 2011 | 340 | 0.390 |
Why?
|
| Menopause | 1 | 2018 | 1535 | 0.390 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2018 | 1635 | 0.390 |
Why?
|
| Bone Substitutes | 2 | 2012 | 241 | 0.390 |
Why?
|
| Diagnostic Errors | 5 | 2017 | 1274 | 0.380 |
Why?
|
| Diagnosis, Differential | 11 | 2020 | 13276 | 0.380 |
Why?
|
| Matrix Metalloproteinase 2 | 3 | 2011 | 481 | 0.380 |
Why?
|
| Klippel-Trenaunay-Weber Syndrome | 2 | 2015 | 71 | 0.380 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2019 | 1949 | 0.370 |
Why?
|
| Ear Diseases | 1 | 2011 | 177 | 0.360 |
Why?
|
| Postoperative Complications | 9 | 2021 | 15126 | 0.360 |
Why?
|
| Exercise Therapy | 1 | 2016 | 903 | 0.360 |
Why?
|
| Tissue Engineering | 2 | 2021 | 1855 | 0.350 |
Why?
|
| Lymphatic System | 2 | 2021 | 259 | 0.350 |
Why?
|
| Wilms Tumor | 2 | 2017 | 339 | 0.350 |
Why?
|
| Disease Management | 2 | 2019 | 2538 | 0.350 |
Why?
|
| Matrix Metalloproteinase 9 | 3 | 2011 | 701 | 0.350 |
Why?
|
| Methylmethacrylates | 1 | 2008 | 74 | 0.350 |
Why?
|
| Age of Onset | 4 | 2019 | 3333 | 0.340 |
Why?
|
| Nipples | 1 | 2009 | 192 | 0.340 |
Why?
|
| Severity of Illness Index | 6 | 2019 | 16020 | 0.340 |
Why?
|
| Breast | 6 | 2017 | 1822 | 0.330 |
Why?
|
| Siblings | 1 | 2012 | 820 | 0.330 |
Why?
|
| Bone Wires | 1 | 2008 | 124 | 0.330 |
Why?
|
| Prostheses and Implants | 2 | 2017 | 1346 | 0.330 |
Why?
|
| Adiposity | 1 | 2017 | 1747 | 0.320 |
Why?
|
| Fibroma | 1 | 2009 | 214 | 0.320 |
Why?
|
| Skull Neoplasms | 1 | 2008 | 175 | 0.320 |
Why?
|
| Nevus | 2 | 2021 | 197 | 0.320 |
Why?
|
| Receptors, Progesterone | 1 | 2012 | 1121 | 0.310 |
Why?
|
| Signal Transduction | 6 | 2021 | 23997 | 0.310 |
Why?
|
| Neovascularization, Physiologic | 4 | 2013 | 1423 | 0.310 |
Why?
|
| Family Health | 1 | 2012 | 1287 | 0.310 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2020 | 3421 | 0.310 |
Why?
|
| Neurocutaneous Syndromes | 1 | 2007 | 39 | 0.310 |
Why?
|
| Scalp Dermatoses | 1 | 2007 | 52 | 0.300 |
Why?
|
| Body Image | 3 | 2017 | 601 | 0.300 |
Why?
|
| Orbit | 3 | 2010 | 430 | 0.300 |
Why?
|
| Retrospective Studies | 29 | 2020 | 72608 | 0.300 |
Why?
|
| Polymerase Chain Reaction | 5 | 2021 | 6294 | 0.300 |
Why?
|
| Self Concept | 4 | 2017 | 1030 | 0.300 |
Why?
|
| Middle Aged | 27 | 2021 | 215054 | 0.300 |
Why?
|
| Embolization, Therapeutic | 3 | 2011 | 1388 | 0.290 |
Why?
|
| Thigh | 1 | 2007 | 232 | 0.290 |
Why?
|
| Weight Loss | 3 | 2021 | 2495 | 0.290 |
Why?
|
| Alleles | 4 | 2021 | 7101 | 0.290 |
Why?
|
| Receptors, Androgen | 1 | 2012 | 1061 | 0.280 |
Why?
|
| Craniofacial Abnormalities | 1 | 2008 | 326 | 0.280 |
Why?
|
| Hamartoma | 1 | 2007 | 232 | 0.270 |
Why?
|
| Finger Injuries | 2 | 2007 | 136 | 0.270 |
Why?
|
| DNA Mutational Analysis | 4 | 2019 | 4312 | 0.270 |
Why?
|
| Phlebotomy | 1 | 2005 | 136 | 0.270 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-2 | 1 | 2004 | 67 | 0.270 |
Why?
|
| Suction | 2 | 2016 | 262 | 0.270 |
Why?
|
| Treatment Outcome | 24 | 2020 | 62344 | 0.270 |
Why?
|
| DNA | 2 | 2016 | 7166 | 0.270 |
Why?
|
| Median Nerve | 1 | 2005 | 127 | 0.260 |
Why?
|
| Statistics, Nonparametric | 5 | 2011 | 2935 | 0.260 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-1 | 1 | 2004 | 153 | 0.260 |
Why?
|
| Follow-Up Studies | 15 | 2017 | 39302 | 0.260 |
Why?
|
| Anti-Inflammatory Agents | 2 | 2011 | 1801 | 0.260 |
Why?
|
| Disease Progression | 8 | 2015 | 13308 | 0.250 |
Why?
|
| Cerebral Palsy | 1 | 2008 | 433 | 0.250 |
Why?
|
| Lip | 2 | 2018 | 193 | 0.250 |
Why?
|
| Receptors, Estrogen | 1 | 2012 | 2176 | 0.250 |
Why?
|
| Matrix Metalloproteinases | 1 | 2006 | 407 | 0.240 |
Why?
|
| Fingers | 2 | 2012 | 521 | 0.240 |
Why?
|
| Cyclooxygenase Inhibitors | 1 | 2005 | 393 | 0.240 |
Why?
|
| Fibrin Tissue Adhesive | 2 | 2015 | 79 | 0.240 |
Why?
|
| Facial Asymmetry | 3 | 2009 | 175 | 0.230 |
Why?
|
| Endothelium, V |